1. Home
  2. Research
  3. Research Groups
  4. Molecular Pathology of Cancer Group

Molecular Pathology of Cancer Group

Search for publications

Only original articles, editorials, guidelines.

  • Cortés A, López-Miranda E, Fernández-Ortega A, Carañana V, Servitja S, Urruticoechea A, Lema-Roso L, Márquez A, Lazaris A, Alcalá-López D, Mina L, Gener P, Rodríguez-Morató J, Antonarelli G, Llombart-Cussac A, Pérez-García J, Cortés J.

    Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.

    BREAST . 78: 103834-103834. Number of citations: 4

    [doi:10.1016/j.breast.2024.103834]

  • Garcia-Donas, Jesus, Garrigos, Laia, Lainez, Nuria, Santaballa, Ana, Redondo, Andres, Cueva, Juan Fernando, Rubio, M. Jesus, Prieto, Mario, Lopez-Guerrero, Jose Antonio, Garcia-Casado, Zaida, Barquin, Aranzanzu, Grande, Enrique, Alia, Eva Guerra, Sevillano, Elena, Bover, Isabel, Grazioso, Tatiana P., Sanchez-Escribano, Ramon, Hurtado, Alicia, Navarro, Paloma, Rodriguez-Moreno, Juan Francisco.

    Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: the Greko II study (GETHI2013-01)

    Clinical & Translational Oncology . 27(7): 3223-3231. Number of citations: 1

    [doi:10.1007/s12094-024-03827-4]

  • Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin N.

    FIGO 2023 staging for endometrial cancer, when, if it is not now?

    EUROPEAN JOURNAL OF CANCER . 213: 115115-115115. Number of citations: 9

    [doi:10.1016/j.ejca.2024.115115]

  • Cortés-Salgado A, Serrano JJ, Cordero Pereda D, Menacho M, del Rey JM, Del Campo-Albendea L, Saavedra C, Chamorro J, Rosero D, Sotoca P, Guillén-Ponce C, Guerra E, Fernández-Abad M, López-Miranda E, Martínez-Jáñez N, Gion M, Salazar MT, Agudo-Quílez P, Garrido P, Alonso Salinas GL.

    Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae299]

  • Quintela-Fandino M, Bermejo B, Zamora E, Moreno F, Garcia-Saenz JÁ, Pernas S, Martinez Jañez N, Jiménez D, Adrover E, Andrés R, Mourón S, Bueno MJ, Manso L, Viñas G, Alba E, Llombart-Cussac A, Cortes J, Tebar C, Roe DJ, Grant A, Watson A, Colomer R, Mouneimne G.

    High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer.

    CLINICAL CANCER RESEARCH . 30(22): 5094-5104. Number of citations: 15

    [doi:10.1158/1078-0432.CCR-24-1518]

  • Alonso-Gordoa T, Jimenez-Fonseca P, Martinez-Trufero J, Navarro M, Porras I, Rubió-Casadevall J, Arregui Valles M, Basté N, Hernando J, Iglesias Docampo L.

    SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).

    Clinical & Translational Oncology . 26(11): 2902-2916. Number of citations: 9

    [doi:10.1007/s12094-024-03736-6]

  • Perez-Fidalgo JA, Gálvez-Montosa F, Guerra EM, Madariaga A, Manzano A, Martin-Lorente C, Rubio-Pérez MJ, Alarcón J, Barretina-Ginesta MP, Gaba L.

    SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).

    Clinical & Translational Oncology . 26(11): 2758-2770. Number of citations: 15

    [doi:10.1007/s12094-024-03531-3]

  • Verlingue L, Italiano A, Prenen H, Guerra Alia EM, Tosi D, Perets R, Lugowska I, Moiseyenko V, Gumus M, Arslan C, Lindsay CR, Deva S, Taus Á, Oaknin A, Rottey S, Cicin I, Goksu SS, Smolin A, Roselló-Keränen S, Habigt C, Marbach D, Boetsch C, Dejardin D, Sleiman N, Evers S, Richard M, Ardeshir C, Charo J, Kraxner A, Teichgräber V, Keshelava N, Dziadziuszko R.

    Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.

    EBioMedicine . 109: 105374-105374. Number of citations: 18

    [doi:10.1016/j.ebiom.2024.105374]

  • Carretero-Barrio I, Pijuan L, Illarramendi A, Curto D, López-Ríos F, Estébanez-Gallo Á, Castellvi J, Granados-Aparici S, Compañ-Quilis D, Noguera R, Esteban-Rodríguez I, Sánchez-Güerri I, Ramos-Guerra AD, Ortuño JE, Garrido P, Ledesma-Carbayo MJ, Benito A, Palacios J.

    Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology.

    Scientific Reports . 14(1): 24163-24163. Number of citations: 5

    [doi:10.1038/s41598-024-75175-w]

  • Agudo-Quílez P, Martín-Moro F, Antoñana Ugalde S, Blanco-Peláez E, García-Cosío M, Tenelanda A, Lledó Navarro JL, López-Jiménez J, Zamorano Gómez JL.

    Primary Cardiac Aggressive B-Cell Lymphoma Affecting Right Ventricle and Acute Cardiovascular Events: Multidisciplinary Approach.

    Jacc. Case Reports . 29(19): 102562-102562.

    [doi:10.1016/j.jaccas.2024.102562]

  • Guerrero-Zotano Á, Pérez-García JM, Ruiz-Borrego M, Bermejo B, Gil-Gil M, de la Haba J, Alba Conejo E, Quiroga V, Carañana V, Urruticoechea A, Morales S, Bellet M, Antón A, Fernández-Abad M, Sánchez-Rovira P, Calabuig L, Pérez-Escuredo J, Sampayo-Cordero M, Cortés J, Llombart-Cussac A.

    Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score =18: DxCARTES study.

    ESMO Open . 9(10): 103733-103733. Number of citations: 4

    [doi:10.1016/j.esmoop.2024.103733]

  • Alés-Martínez JE, Balmaña J, Sánchez-Rovira P, Salvador Bofill FJ, García Sáenz JÁ, Pimentel I, Morales S, Fernández-Abad M, Lahuerta Martínez A, Ferrer N, Zamora P, Bermejo B, Díaz-Redondo T, López-Ceballos MH, Galán M, Pérez-Escuredo J, Calabuig L, Sampayo M, Pérez-Garcia JM, Cortés J, Llombart-Cussac A.

    Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.

    BREAST . 77: 103780-103780. Number of citations: 2

    [doi:10.1016/j.breast.2024.103780]

  • Moreno-Moreno, Esther, Caniego-Casas, Tamara, Carretero-Barrio, Irene, Cortes, Alfonso, Muriel, Alfonso, Dominguez-Rullan, Jose Antonio, Martin-Gromaz, Carmen, Moreno-Bueno, Gema, Matias-Guiu, Xavier, Palacios, Jose, Perez-Mies, Belen.

    Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors.

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 48(12): 1580-1587. Number of citations: 5

    [doi:10.1097/PAS.0000000000002308]

  • Vaz Batista M, Pérez-García JM, Cortez P, Garrigós L, Fernández-Abad M, Gion M, Martínez-Bueno A, Saavedra C, Teruel I, Fernandez-Ortega A, Servitja S, Ruiz-Borrego M, de la Haba-Rodríguez J, Martrat G, Pérez-Escuredo J, Alcalá-López D, Sampayo-Cordero M, Braga S, Cortés J, Llombart-Cussac A.

    Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial.

    ESMO Open . 9(9): 103699-103699. Number of citations: 33

    [doi:10.1016/j.esmoop.2024.103699]

  • Niedra, Helvijs, Peculis, Raitis, Saksis, Rihards, Mandrika, Ilona, Vilisova, Sofija, Nazarovs, Jurijs, Breiksa, Austra, Gerina, Aija, Earl, Julie, Ruz-Caracuel, Ignacio, Rosas, Marta Gabriela, Pukitis, Aldis, Senterjakova, Natalja, Rovite, Vita.

    Tumor and a-SMA-expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade

    Molecular Oncology . : . Number of citations: 7

    [doi:10.1002/1878-0261.13727]

  • Ruz-Caracuel I, Caniego-Casas T, Alonso-Gordoa T, Carretero-Barrio I, Ariño-Palao C, Santón A, Rosas M, Pian H, Molina-Cerrillo J, Luengo P, Palacios J.

    Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade.

    ENDOCRINE PATHOLOGY . 35(3): 207-218. Number of citations: 13

    [doi:10.1007/s12022-024-09817-0]

  • Gorospe L, Reguero-Callejas ME, Donate-Velasco I.

    Inflammatory Myofibroblastic Tumor of the Pleura With Lung Metastases in an Elderly Patient.

    ARCHIVOS DE BRONCONEUMOLOGIA . : .

    [doi:10.1016/j.arbres.2024.07.024]

  • González-Martínez S, Pérez-Mies B, Cortés J, Palacios J.

    Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape.

    Frontiers in Immunology . 15: 1425212-1425212. Number of citations: 8

    [doi:10.3389/fimmu.2024.1425212]